Renin-angiotensin-aldosterone system in patients with sleep apnoea: Prevalence of primary aldosteronism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 3, 2010, Pages 165-172

  Di Murro, A ^a   Petramala, L ^a   Cotesta, D ^a   Zinnamosca, L ^a   Crescenzi, E ^a   Marinelli, C ^a   Saponara, M ^b   Letizia, C ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

obstructive sleep apnoea; primary aldosteronism; renin angiotensin aldosterone system

Indexed keywords

ADULT; APNEA; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; HYPOPNEA INDEX; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; QUESTIONNAIRE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP APNEA SYNDROME; SLEEP DISORDER; WAIST CIRCUMFERENCE;

ADULT; ALDOSTERONE; FEMALE; HUMANS; HYPERALDOSTERONISM; ITALY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SLEEP APNEA, OBSTRUCTIVE;

EID: 77956300089     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320310366581     Document Type: Article

References (44)

1. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997 ; 157: 1746-1752.
2. Shahar E., Whitney CW, Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001 ; 163: 19-25.
3. Marin JM, Carrizo SJ, Vicente E., and Agusti AG Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005 ; 365: 1046-1053.
4. Arzt M., Young T., Finn L., Skatrud JB, and Bradley TD Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005 ; 172: 1447-1451.
5. Yaggi HK, Concato J., Kernan WN, Lichtman JH, Brass LM, and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005 ; 353: 2034-2041.
6. Munoz R., Duran-Cantolla J., Martínez-Vila E., et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006 ; 37: 2317-2321.
7. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009 ; 51: 434-451.
8. Grote L., Ploch T., Heitmann J., Knaack L., Penzel T., and Peter JH Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999 ; 160: 1875-1882.
9. Peppard PE, Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000 ; 342: 1378-1384.
10. Lavie P., Herer P., and Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J 2000 ; 320: 479-482.
11. Logan AG, Perlikowski SM, Mente A., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001 ; 19: 2271-2277.
12. Fletcher EC, Bao G., and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999 ; 34: 309-314.
13. Yamauchi M., Nakano H., Maekawa J., et al. Oxidative stress in obstructive sleep apnea. Chest 2005 ; 127: 1674-1679.
14. Kato M., Roberts-Thomson P., Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000 21 ; 102: 2607-2610.
15. Johns MW A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991 ; 14: 540-545.
16. Rossi GP, Bernini G., Caliumi C., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 ; 48: 2293-2300.
17. Flemons WW Clinical practice. Obstructive sleep apnea. N Engl J Med 2002 ; 347: 498-504.
18. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993 ; 328: 1230-1235.
19. Tishler PV, Larkin EK, Schluchter MD, and Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003 ; 289: 2230-2337.
20. Kales A., Bixler EO, Cadieux RJ, et al. Sleep apnoea in a hypertensive population. Lancet 1984 ; 2: 1005-1008.
21. Sin DD, Fitzgerald F., Parker JD, Newton G., Floras JS, and Bradley TD Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999 ; 160: 1101-1106.
22. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001 ; 32: 1271-1278.
23. Turkington PM, Allgar V., Bamford J., Wanklyn P., and Elliott MW Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax 2004 ; 59: 367-371.
24. Bradley TD, Floras JS Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009 ; 373: 82-93.
25. Friedman O., Logan AG The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. Am J Hypertens 2009 ; 22: 474-483.
26. Goodfriend TL Obesity, sleep apnea, aldosterone, and hypertension. Curr Hypertens Rep 2008 ; 10: 222-226.
27. Mosso L., Carvajal C., González A., et al. Primary aldosteronism and hypertensive disease. Hypertension 2003 ; 42: 161-165.
28. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, and Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002 ; 40: 892-896.
29. Lim PO CAPPP trial. Captopril Prevention Project. Lancet 1999 ; 353: 1793 ; author reply 1795-1796.
30. Calhoun DA, Nishizaka MK, Zaman MA, and Harding SM Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004 ; 125: 112-117.
31. Young WF, Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003 ; 144: 2208-2213.
32. Pimenta E., Calhoun DA, and Oparil S. Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis 2009 ; 51: 371-380.
33. Raff H., Roarty TP Renin, ACTH, and aldosterone during acute hypercapnia and hypoxia in conscious rats. Am J Physiol 1988 ; 254: R431-435.
34. Maillard D., Fineyre F., Dreyfuss D., et al. Pressure-heart rate responses to alpha-adrenergic stimulation and hormonal regulation in normotensive patients with obstructive sleep apnea. Am J Hypertens 1997 ; 10: 24-31.
35. Fletcher EC, Orolinova N., and Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002 ; 92: 627-633.
36. Hoffstein V., Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992 ; 5: 377-381.
37. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989 ; 27: 613-622.
38. Grunstein R., Wilcox I., Yang TS, Gould Y., and Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993 ; 17: 533-540.
39. Shinohara E., Kihara S., Yamashita S., et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997 ; 241: 11-18.
40. Young T., Shahar E., Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002 ; 162: 893-900.
41. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000 ; 85: 1151-1158.
42. Mortimore IL, Marshall I., Wraith PK, Sellar RJ, and Douglas NJ Neck and total body fat deposition in non-obese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 1998 ; 157: 280-283.
43. Ryan CM, Bradley TD Pathogenesis of obstructive sleep apnea. J Appl Physiol 2005 ; 99: 2440-2250.
44. Rubinstein I., Colapinto N., Rotstein LE, Brown IG, and Hoffstein V. Improvement in upper airway function after weight loss in patients with obstructive sleep apnea. Am Rev Respir Dis 1988 ; 138: 1192-1195.